Marinus Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript
Hey, everyone. It's Alethia Young here. I cover large-cap, small, mid-cap at Cantor. I'm covering biotech, of course, last time I checked, I think. Very happy to have Marinus here with us -- Marinus Pharmaceuticals. We have Dr. Scott Braunstein, the CEO and Director; and we have Steve Pfanstiel, who is the CFO. So we are doing a fireside chat for 30 minutes or so. So I guess Scott, maybe just to tee it off, I mean it's been actually very, very exciting the past 12 months at Marinus and then the past few weeks as well. So can you talk about that for people just to level set where we are, and some of the accomplishments that you guys have seen over the past 12 months?
Yes, I'd be happy to, Alethia. I took over as CEO a little bit more than two years ago, and our focus was 100% on the IV program. We had some really compelling Phase 2 data, met with the agency, and moved forward with the Phase 3 registrational trial for the IV treatment of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
